Literature DB >> 22144280

High-throughput flow cytometry bead-based multiplex assay for identification of Rho GTPase inhibitors.

Zurab Surviladze1, Susan M Young, Larry A Sklar.   

Abstract

Rho family GTPases and their effector proteins regulate a wide range of cell signaling pathways. In normal physiological conditions, their activity is tightly controlled and it is not surprising that their aberrant activation contributes to tumorigenesis or other diseases. For this reason, the identification of small, cell permeable molecules capable of inhibition of Rho GTPases can be extraordinarily useful, particularly if they are specific and act reversibly.Herein, we describe a flow cytometric assay, which allows us to measure the activity of six small GTPases simultaneously. GST-tagged small GTPases are bound to six glutathione bead sets each set having a different intensity of red fluorescence at a fixed wavelength. The coated bead sets were washed, combined, and dispensed into 384-well plates with test compounds, and fluorescent-GTP binding was used as the read-out.This multiplex bead-based assay was successfully used for to identify both general and selective inhibitors of Rho family GTPases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22144280      PMCID: PMC4467469          DOI: 10.1007/978-1-61779-442-1_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  20 in total

1.  Fluorescent BODIPY-GTP analogs: real-time measurement of nucleotide binding to G proteins.

Authors:  D P McEwen; K R Gee; H C Kang; R R Neubig
Journal:  Anal Biochem       Date:  2001-04-01       Impact factor: 3.365

2.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

Review 3.  Rho GTPases in cell biology.

Authors:  Sandrine Etienne-Manneville; Alan Hall
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

Review 4.  RHO-GTPases and cancer.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

5.  Rational design and characterization of a Rac GTPase-specific small molecule inhibitor.

Authors:  Yuan Gao; J Bradley Dickerson; Fukun Guo; Jie Zheng; Yi Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

6.  Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases.

Authors:  Adam Shutes; Cercina Onesto; Virginie Picard; Bertrand Leblond; Fabien Schweighoffer; Channing J Der
Journal:  J Biol Chem       Date:  2007-10-11       Impact factor: 5.157

7.  Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.

Authors:  Matthew J Saunders; Bruce S Edwards; Jingshu Zhu; Larry A Sklar; Steven W Graves
Journal:  Curr Protoc Cytom       Date:  2010-10

Review 8.  Rho GTPase expression in tumourigenesis: evidence for a significant link.

Authors:  Teresa Gómez del Pulgar; Salvador A Benitah; Pilar F Valerón; Carolina Espina; Juan Carlos Lacal
Journal:  Bioessays       Date:  2005-06       Impact factor: 4.345

9.  Flow cytometry for real-time measurement of guanine nucleotide binding and exchange by Ras-like GTPases.

Authors:  Samantha L Schwartz; Mathewos Tessema; Tione Buranda; Olena Pylypenko; Alexey Rak; Peter C Simons; Zurab Surviladze; Larry A Sklar; Angela Wandinger-Ness
Journal:  Anal Biochem       Date:  2008-07-08       Impact factor: 3.365

Review 10.  Rho GTPases in cancer cell biology.

Authors:  Francisco M Vega; Anne J Ridley
Journal:  FEBS Lett       Date:  2008-05-05       Impact factor: 4.124

View more
  16 in total

1.  Genetic barcoding with fluorescent proteins for multiplexed applications.

Authors:  Cameron A Smurthwaite; Wesley Williams; Alexandra Fetsko; Darin Abbadessa; Zachary D Stolp; Connor W Reed; Andre Dharmawan; Roland Wolkowicz
Journal:  J Vis Exp       Date:  2015-04-14       Impact factor: 1.355

2.  Drug Repurposing from an Academic Perspective.

Authors:  Tudor I Oprea; Julie E Bauman; Cristian G Bologa; Tione Buranda; Alexandre Chigaev; Bruce S Edwards; Jonathan W Jarvik; Hattie D Gresham; Mark K Haynes; Brian Hjelle; Robert Hromas; Laurie Hudson; Debra A Mackenzie; Carolyn Y Muller; John C Reed; Peter C Simons; Yelena Smagley; Juan Strouse; Zurab Surviladze; Todd Thompson; Oleg Ursu; Anna Waller; Angela Wandinger-Ness; Stuart S Winter; Yang Wu; Susan M Young; Richard S Larson; Cheryl Willman; Larry A Sklar
Journal:  Drug Discov Today Ther Strateg       Date:  2011

3.  A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients.

Authors:  Yuna Guo; S Ray Kenney; Linda Cook; Sarah F Adams; Teresa Rutledge; Elsa Romero; Tudor I Oprea; Larry A Sklar; Edward Bedrick; Charles L Wiggins; Huining Kang; Lesley Lomo; Carolyn Y Muller; Angela Wandinger-Ness; Laurie G Hudson
Journal:  Clin Cancer Res       Date:  2015-06-12       Impact factor: 12.531

Review 4.  The intersection of flow cytometry with microfluidics and microfabrication.

Authors:  Menake E Piyasena; Steven W Graves
Journal:  Lab Chip       Date:  2014-03-21       Impact factor: 6.799

Review 5.  Flow Cytometry: Impact on Early Drug Discovery.

Authors:  Bruce S Edwards; Larry A Sklar
Journal:  J Biomol Screen       Date:  2015-03-24

6.  Quantitative bead-based flow cytometry for assaying Rab7 GTPase interaction with the Rab-interacting lysosomal protein (RILP) effector protein.

Authors:  Jacob O Agola; Daniel Sivalingam; Daniel F Cimino; Peter C Simons; Tione Buranda; Larry A Sklar; Angela Wandinger-Ness
Journal:  Methods Mol Biol       Date:  2015

Review 7.  Druggable targets in the Rho pathway and their promise for therapeutic control of blood pressure.

Authors:  Rachel A Dee; Kevin D Mangum; Xue Bai; Christopher P Mack; Joan M Taylor
Journal:  Pharmacol Ther       Date:  2018-09-04       Impact factor: 12.310

8.  Characterization of a Cdc42 protein inhibitor and its use as a molecular probe.

Authors:  Lin Hong; S Ray Kenney; Genevieve K Phillips; Denise Simpson; Chad E Schroeder; Julica Nöth; Elsa Romero; Scarlett Swanson; Anna Waller; J Jacob Strouse; Mark Carter; Alexandre Chigaev; Oleg Ursu; Tudor Oprea; Brian Hjelle; Jennifer E Golden; Jeffrey Aubé; Laurie G Hudson; Tione Buranda; Larry A Sklar; Angela Wandinger-Ness
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

9.  A Pan-GTPase Inhibitor as a Molecular Probe.

Authors:  Lin Hong; Yuna Guo; Soumik BasuRay; Jacob O Agola; Elsa Romero; Denise S Simpson; Chad E Schroeder; Peter Simons; Anna Waller; Matthew Garcia; Mark Carter; Oleg Ursu; Kristine Gouveia; Jennifer E Golden; Jeffrey Aubé; Angela Wandinger-Ness; Larry A Sklar
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

Review 10.  Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor Progression.

Authors:  Shannon Patricia Fortin Ensign; Ian T Mathews; Marc H Symons; Michael E Berens; Nhan L Tran
Journal:  Front Oncol       Date:  2013-10-04       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.